Treatment of Juvenile Absence Epilepsy in Patients Aged 16 Years and Older
Juvenile absence epilepsy extending into adulthood — starting at age 16 — presents a distinct clinical picture. This protocol outlines the evidence-based treatment pathway for younger adults in this age range.
Patient Population
Younger adults aged 16 years and older with juvenile absence epilepsy. Age-specific factors inform both the treatment selection and the overall management strategy for this group.
Treatment Approach
The treatment approach for this population involves antiepileptic drug therapy — specifically, a combination strategy. Which agents to combine, how to structure the regimen, and in what sequence are covered in the full protocol.
References
Younger adults (16 to 59 years of age)
Monotherapy with all indicated AEDs should be attempted before initiating combination therapy.
View source ↗